JPWO2020095971A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020095971A5 JPWO2020095971A5 JP2020555569A JP2020555569A JPWO2020095971A5 JP WO2020095971 A5 JPWO2020095971 A5 JP WO2020095971A5 JP 2020555569 A JP2020555569 A JP 2020555569A JP 2020555569 A JP2020555569 A JP 2020555569A JP WO2020095971 A5 JPWO2020095971 A5 JP WO2020095971A5
- Authority
- JP
- Japan
- Prior art keywords
- glutaminase
- inhibitor
- cells
- activity
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018210300 | 2018-11-08 | ||
| JP2018210300 | 2018-11-08 | ||
| PCT/JP2019/043570 WO2020095971A1 (ja) | 2018-11-08 | 2019-11-07 | 老化細胞を除去する方法、および老化細胞の調製方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020095971A1 JPWO2020095971A1 (ja) | 2021-10-07 |
| JPWO2020095971A5 true JPWO2020095971A5 (https=) | 2022-11-14 |
| JP7570100B2 JP7570100B2 (ja) | 2024-10-21 |
Family
ID=70612079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020555569A Active JP7570100B2 (ja) | 2018-11-08 | 2019-11-07 | 老化細胞を除去する方法、および老化細胞の調製方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20220119768A1 (https=) |
| EP (1) | EP3878470A4 (https=) |
| JP (1) | JP7570100B2 (https=) |
| CN (1) | CN112996541B (https=) |
| WO (1) | WO2020095971A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7016983B1 (ja) * | 2021-01-21 | 2022-02-07 | 株式会社ユーグレナ | Ｇｌｓ１遺伝子阻害用化粧料組成物、ｇｌｓ１遺伝子阻害剤、老化細胞除去用化粧料組成物及び老化細胞除去剤 |
| JP2024521770A (ja) * | 2021-05-26 | 2024-06-04 | ユニティ バイオテクノロジー インコーポレイテッド | 網膜血管症を治療する方法 |
| EP4431102A4 (en) * | 2021-11-10 | 2025-10-29 | Lifeceutix Co Ltd | Senescent Cell Elimination Compositions and Their Uses |
| CN116008519A (zh) * | 2022-12-14 | 2023-04-25 | 贵州医科大学 | 一种新型细胞衰老检测试剂盒及其检测方法和应用 |
| CN120752045A (zh) * | 2023-02-27 | 2025-10-03 | 协和医药化工股份有限公司 | 细胞衰老的预防或改善剂 |
| CN121648114A (zh) * | 2026-02-06 | 2026-03-13 | 北京大学 | 一种小分子化合物在制备用于抗衰老的产品中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2141241A1 (en) * | 2008-07-03 | 2010-01-06 | Helmholtz-Zentrum für Infektionsforschung GmbH | Senescence cells and methods for its production |
| KR20160100408A (ko) * | 2014-01-06 | 2016-08-23 | 리젠 파마슈티컬스 소시에떼 아노님 | 신규한 글루타미나제 저해제 |
| US10221459B2 (en) * | 2014-05-13 | 2019-03-05 | Case Western Reserve University | Compositions and methods of treating cancer harboring PIKC3A mutations |
| US20180193458A1 (en) * | 2015-07-08 | 2018-07-12 | Unity Biotechnology, Inc. | Compositions and methods for treating senescence-associated diseases and disorders |
| US20170348398A1 (en) * | 2016-06-03 | 2017-12-07 | Vanderbilt University | Compositions and methods for decreasing blood glucagon levels |
-
2019
- 2019-11-07 US US17/291,687 patent/US20220119768A1/en active Pending
- 2019-11-07 WO PCT/JP2019/043570 patent/WO2020095971A1/ja not_active Ceased
- 2019-11-07 JP JP2020555569A patent/JP7570100B2/ja active Active
- 2019-11-07 CN CN201980073708.0A patent/CN112996541B/zh active Active
- 2019-11-07 EP EP19882083.9A patent/EP3878470A4/en active Pending
-
2025
- 2025-10-31 US US19/375,916 patent/US20260049282A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2020095971A5 (https=) | ||
| ES2550357T3 (es) | Combinación farmacéutica para su uso en el control glucémico en pacientes de diabetes de tipo 2 | |
| JP5615805B2 (ja) | 細胞ストレス応答の調節を通したアルツハイマー病および関連障害の処置のための新たな治療アプローチ | |
| TWI898177B (zh) | 化合物之調配物及其用途 | |
| JP4643760B2 (ja) | Ｄｐｐ−ｉｖ阻害薬と他の糖尿病治療薬との併用又は組み合せからなる医薬 | |
| KR102197429B1 (ko) | 심혈관 질환의 치료를 위한 약학 조성물 및 방법 | |
| BR112015010063A2 (pt) | método para o tratamento ou prevenção de um evento cardiovascular em um sujeito com doença vascular aterosclerótica, utilização de um composto de fórmula (i), um derivado da colquicina conhecido e/ou um sal do mesmo, composição para a prevenção ou tratamento de um evento cardiovascular em um sujeito com doença vascular aterosclerótica, método e regime para reduzir ou prevenir a inflamação induzida por cristal de colesterol no interior das placas ateroscleróticas em um sujeito, regime para o tratamento ou prevenção de um acidente cardiovascular em um indivíduo | |
| JP2008515905A5 (https=) | ||
| HRP20150838T1 (hr) | Sastavi koji sadrže modulatore receptora sfingozin 1 fosfata (s1p) | |
| BR0309670A (pt) | Compostos derivados dicetohidrazina e drogas contendo os compostos como o ingrediente ativo | |
| HRP20220058T1 (hr) | Sastavi i metode za smanjenje velikih neželjenih kardiovaskularnih događaja | |
| JP2011148806A (ja) | 重症心不全の治療方法およびその薬剤 | |
| JP2011510014A5 (https=) | ||
| RU2008149246A (ru) | Соединение на основе терефталата, композиции и их применение в качестве ингибиторов интегразы вич | |
| JP2022546414A5 (https=) | ||
| JP2016525104A5 (https=) | ||
| JP2016512198A5 (https=) | ||
| JP2016530238A5 (https=) | ||
| CN101257898A (zh) | 艾司佐匹克隆与o-去甲基文拉法辛的组合以及治疗绝经期和心境障碍、焦虑症和认知障碍的方法 | |
| JP2005532321A (ja) | 呼吸器の疾患および状態の、選択的ｉＮＯＳ阻害剤とＰＤＥ阻害剤による治療方法、ならびにそのための組成物 | |
| AU2021288679A1 (en) | Methods for treating or preventing chronic kidney disease | |
| KR20170106485A (ko) | 요산 또는 통풍 질환의 예방 또는 치료 | |
| WO2011057110A1 (en) | Gpr109a agonists for the treatment of cerebral ischemia | |
| JP2006505582A (ja) | 肺高血圧症の処置を目的としたｎ−｛５−［４−（４−メチルピペラジノメチル）−ベンゾイルアミド］−２−メチルフェニル｝−４−（３−ピリジル）−２−ピリジン−アミンの使用 | |
| JP2014224108A5 (https=) |